the new controller becomes part of the scale-X platform for a cost-effective, low-footprint and user-friendly solution for large-scale viral and advanced therapy manufacturing. The controller ...

The scale-X™ nitro controller delivers high productivity while enabling rapid scalability from R&D to commercial production in just eight months. The new controller complements the existing NevoLine™ ...

Designed to operate both the 200 and 600 m² scale-X nitro bioreactors, the new controller becomes part of the scale-X platform for a cost-effective, low-footprint and user-friendly solution for ...

Chief Investment Officer and Global Head of Fixed Income at Nuveen. "Given policy uncertainties and the lack of clear market guidance, we are reluctant to make large directional bets." ...

Over my forty years or so in and around dealing rooms and financial markets, I have heard many theories as to how to approach that problem and have settled on a process that has worked for me.